Literature DB >> 15766336

Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care.

A C Gordon1, H E Oakervee, B Kaya, J M Thomas, M J Barnett, A Z S Rohatiner, T A Lister, J D Cavenagh, C J Hinds.   

Abstract

To determine the incidence and outcome of critical illness amongst the total population of hospital patients with haematological malignancy (including patients treated on the ward as well as those admitted to the intensive care unit), consecutive patients with haematological malignancy were prospectively studied. One hundred and one of the 1437 haemato-oncology admissions (7%) in 2001 were complicated by critical illness (26% of all new referrals). Fifty-four (53%) of these critically ill patients survived to leave hospital and 33 (34%) were still alive after 6 months. The majority (77/101) were not admitted to the intensive care unit but were managed on the ward, often with the assistance of the intensive care team. Independent risk factors for dying in hospital included hepatic failure (odds ratio 5.3, 95% confidence intervals 1.3-21.2) and central nervous system failure (odds ratio 14.5, 95% confidence intervals 1.7-120.5). No patient with four or more organ failures or a Simplified Acute Physiology Score II >/= 65 survived to leave hospital. There was close agreement between actual and predicted mortality with increasing Simplified Acute Physiology Score II for all patients, including those not admitted to intensive care.

Entities:  

Mesh:

Year:  2005        PMID: 15766336     DOI: 10.1111/j.1365-2044.2005.04139.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  11 in total

1.  Cost effectiveness of intensive care in a low resource setting: A prospective cohort of medical critically ill patients.

Authors:  Hajrunisa Cubro; Rabija Somun-Kapetanovic; Guillaume Thiery; Daniel Talmor; Ognjen Gajic
Journal:  World J Crit Care Med       Date:  2016-05-04

2.  Factors Associated With Clinical Deterioration Among Patients Hospitalized on the Wards at a Tertiary Cancer Hospital.

Authors:  Patrick G Lyons; Jeff Klaus; Colleen A McEvoy; Peter Westervelt; Brian F Gage; Marin H Kollef
Journal:  J Oncol Pract       Date:  2019-07-15       Impact factor: 3.840

3.  Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study.

Authors:  Andry Van de Louw; Kathleen Twomey; Nicholas Habecker; Kevin Rakszawski
Journal:  Ann Hematol       Date:  2020-09-12       Impact factor: 3.673

4.  Non-invasive ventilation in immunocompromised patients with acute hypoxemic respiratory failure.

Authors:  Lorenzo Del Sorbo; Angela Jerath; Martin Dres; Matteo Parotto
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

5.  The role of a critical care outreach service in the management of patients with haematological malignancy.

Authors:  Leila Taheri; Rathai Anandanadesan; Hugues de Lavallade; Eirini Pagkalidou; Antonio Pagliuca; Ghulam Mufti; Georg Auzinger; Victoria Metaxa
Journal:  J Intensive Care Soc       Date:  2019-06-10

6.  Retrospective analysis of outcome of women with breast or gynaecological cancer in the intensive care unit.

Authors:  Marlies Ostermann; Mario Raimundo; Anna Williams; Craig Whiteley; Richard Beale
Journal:  JRSM Short Rep       Date:  2013-01-14

Review 7.  Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematology.

Authors:  Sandra Malak; Jean-Jacques Sotto; Joël Ceccaldi; Philippe Colombat; Philippe Casassus; Dominique Jaulmes; Henri Rochant; Morgane Cheminant; Yvan Beaussant; Robert Zittoun; Dominique Bordessoule
Journal:  Adv Hematol       Date:  2014-10-01

Review 8.  The prognostic factors for patients with hematological malignancies admitted to the intensive care unit.

Authors:  Qian Cheng; Yishu Tang; Qing Yang; Erhua Wang; Jing Liu; Xin Li
Journal:  Springerplus       Date:  2016-11-29

Review 9.  A systematic review of prognostic factors at the end of life for people with a hematological malignancy.

Authors:  Elise Button; Raymond Javan Chan; Shirley Chambers; Jason Butler; Patsy Yates
Journal:  BMC Cancer       Date:  2017-03-23       Impact factor: 4.430

10.  Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Peter A Hampshire; Catherine A Welch; Lawrence A McCrossan; Katharine Francis; David A Harrison
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.